>synchron
>garnering some $363 million in investments
And USG Contracts and Grants including a grant to Carnegie Melon which reads in part:
"To address this unmet need, Synchron, Inc. has developed the Stentrodetm System, a fully implantable BCI that communicates wirelessly to an external interface on a mobile computing platform. The Stentrodetm BCI is a 16-channel array of sensors integrated into a self-expanding, stent-like substrate. The Stentrodetm is delivered endovascularly via a catheter to the superior sagittal sinus, where it measures volitionally-modulated neural signals from the leg area of motor cortex in both hemispheres. A fully implantable, wireless telemetry unit digitizes and transmits the neural signals from the Stentrodetm to an external mobile processor that converts the neural signals into commands for operating a computer or other assistive device, such as a speller for communication. The Synchron team has already initiated a first-in-human trial of the Stentrodetm BCI system in Melbourne, Australia, under approvals granted by the Therapeutic Goods Administration (TGA) of Australia and the IRB of the Royal Melbourne Hospital."
If the device can enable a person's muscles to move, can it also disable that ability?
https://www.usaspending.gov/award/ASST_NON_UG3NS120191_7529
https://www.usaspending.gov/keyword_search/Synchron